Showing 121 - 140 results of 1,780 for search '(( 10 ((per decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 1 b decrease ))*', query time: 0.22s Refine Results
  1. 121
  2. 122
  3. 123

    Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial by El Hajj, Maguy

    Published 2015
    “…Secondary outcomes constitute quality-of-life adjustment as well as cost analysis of program resources consumed, including per case and patient outcome. Discussion: If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease the smoking burden. …”
    Get full text
    Get full text
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129

    Tests of a diamond field-assisted positron moderator by Al-Qaradawi, I. Y.

    Published 2002
    “…The film was coated on one side with a 200 nm gold electrode and on the other with a similar thickness of gold in the form of a fine mesh (10 μm lines, 40 μm spaces) in the central part of the diamond surface and a solid edge for electrical contact. …”
    Get full text
    Get full text
    Get full text
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134

    Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit by Al-Sulaiti, Fatima Khalifa

    Published 2024
    “…Gentamicin dose regimen continuations, dose regimen decreases and dose regimen discontinuations were inappropriately applied in 27% (n = 10), 25% (n = 2) and 14% (n = 1) of the times, respectively. …”
    Get full text
    Get full text
    Get full text
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139

    A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications by Elewa, Hazem

    Published 2017
    “…Data were identified for the genes coding for the cytochrome P450 (CYP) enzymes: CYP2C8, CYP2C19, CYP2A6, CYP2D6, CYP2B6, and the P-glycoprotein drug transporter. Adverse effects of amodiaquine were more common in patients with decreased CYP2C8 metabolism. …”
    Get full text
    Get full text
  20. 140